Rino Rappuoli - Concepedia

Author

Rino Rappuoli

Also Known As

Francesco Santoro, Giorgio Parisi, Mariagrazia Pizza, Ogohara, Cassandra, Olivier Provendier, R RAPPUOLI, R Rappuoli, R Rappuoli4, R. RAPPUOLI, R. Rappuoli

1.3K

Publications

75.5K

Citations

142

H-Index

221

Concepts

All Affiliations

Novartis (Italy)University of Siena Toscana Life Sciences University of Padua Newron Pharmaceuticals (Italy)

About

Rino Rappuoli is an author at Novartis (Italy) specializing in medicine, immunology, and microbiology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	92	283	27.2K
2	Natural Sciences	37	60	4.7K
3	Public Health	11	12	843
4	Health Sciences	9	9	1.3K
5	Engineering	3	3	753

Rino Rappuoli

483

Publications

51.1K

Citations

116

H-Index

Page 1

	Year	Citations
Genome analysis of multiple pathogenic isolates of <i>Streptococcus agalactiae</i> : Implications for the microbial “pan-genome” Hervé Tettelin, Vega Masignani, Michael J. Cieslewicz, Proceedings of the National Academy of Sciences	2005	2.6K
<i>cag</i> , a pathogenicity island of <i>Helicobacter pylori,</i> encodes type I-specific and disease-associated virulence factors Stefano Censini, Christina Lange, Z Xiang, Proceedings of the National Academy of Sciences	1996	1.9K
Complete Genome Sequence of <i>Neisseria meningitidis</i> Serogroup B Strain MC58 Hervé Tettelin, Nigel J. Saunders, John F. Heidelberg, Science MedicineGeneticsPathogenesisVirulence Factor2,272,351-Base Pair Genome	2000	1.1K
A universal vaccine for serogroup B meningococcus Marzia Monica Giuliani, Jeannette Adu‐Bobie, Maurizio Comanducci, Proceedings of the National Academy of Sciences VaccinationVaccinologyReverse VaccinologyVaccine DevelopmentVaccine Target	2006	717
An efficient method to make human monoclonal antibodies from memory B cells: potent neutralization of SARS coronavirus Elisabetta Traggiai, Stephan Becker, Kanta Subbarao, Nature Medicine	2004	705
Nonviral delivery of self-amplifying RNA vaccines Andrew J. Geall, Ayush Verma, Gillis R. Otten, Proceedings of the National Academy of Sciences EngineeringImmunologyLipid NanoparticlesGene DeliveryBiomedical Engineering	2012	648
Analysis of expression of CagA and VacA virulence factors in 43 strains of Helicobacter pylori reveals that clinical isolates can be divided into two major types and that CagA is not necessary for expression of the vacuolating cytotoxin Z Xiang, Stefano Censini, P F Bayeli, Infection and Immunity Vacuolating CytotoxinIi BacteriaVirulence FactorVaca Virulence FactorsPathogenesis	1995	593
Tyrosine phosphorylation of the<i>Helicobacter pylori</i>CagA antigen after<i>cag</i>-driven host cell translocation Markus Stein, Rino Rappuoli, Antonello Covacci Proceedings of the National Academy of Sciences	2000	584
Coxsackie B4 virus infection of β cells and natural killer cell insulitis in recent-onset type 1 diabetic patients Francesco Dotta, Stefano Censini, Astrid G. S. van Halteren, Proceedings of the National Academy of Sciences ImmunologyViral PathogenesisPathologyDiabetic PatientsCell Culture	2007	558
Identification of a Universal Group B <i>Streptococcus</i> Vaccine by Multiple Genome Screen Domenico Maione, Immaculada Margarit, C. Daniela Rinaudo, Science ImmunologyBacterial PathogensReverse VaccinologyVaccine TargetInfection Control	2005	543

Page 1